ImmunoGen Competitors and Similar CompaniesClear all
ADC Therapeutics's competitors and similar companies include Puma Biotechnology.
 ADC Therapeutics ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers. |  Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | |
Founding Date | Founding Date 2010 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Epalinges, CH HQ London, GB New Providence, US | Locations Los Angeles, US HQ |
Employees | Employees 1162% increase | Employees 27214% decrease |
Valuation ($) | Valuation ($) 295.9 m | Valuation ($) 136.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $81.4m (FY, 2025) | Revenue (est.) $228.4m (FY, 2025) |
Cost of goods | Cost of goods $5.1m (FY, 2025) | Cost of goods $58.2m (FY, 2025) |
Gross profit | Gross profit $76.3m (FY, 2025) | Gross profit $170.2m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 526m | Total funding raised $ 172m |
For sources of this data, please see the company profile
View Company Profiles
Puma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company